Thoracoscopic Sympathectomy for Blushing

Thoracoscopic Sympathectomy for Blushing. A Prospective Randomised Trial.

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00225069

Enrollment

100

Registered

2005-09-23

Start date

2005-09-30

Completion date

2012-01-31

Last updated

2012-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Blushing

Keywords

Facial blushing, Sympathectomy

Brief summary

To determine outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing and investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy.

Detailed description

To determine the outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing. In addition, following randomization investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy. Includes QoL before and 12 months after surgery

Interventions

PROCEDURELevel of sympathectomy

T2 sympathectomy or T2-T3 sympathectomy

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Isolated disabling facial blushing * Over 18 years of age * Willing to be randomized

Exclusion criteria

* Primary hyperhidrosis in palms or axillae * Previous lung surgery * Bradycardia * Arrythmias * Pregnancy

Design outcomes

Primary

Measure	Time frame
Effect of operation. Side effects: compensatory and gustatory sweating.	12 months after surgery

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026